Rheumatology
FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.
16 Aug, 2021 | 01:22h | UTCCommentaries:
CDC, FDA recommend COVID booster for immune-compromised – CIDRAP
FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT
Covid booster: US approves third jab for the immunocompromised – BBC
CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR
6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR
CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN
Commentary on Twitter
The Infectious Diseases Society of America (IDSA) supports the @FDA and @CDCgov's decision to authorize a supplemental vaccine dose for immunocompromised patients.
Read our statement: https://t.co/odzzSgIxnY pic.twitter.com/4PZfUwpjhM
— IDSA (@IDSAInfo) August 13, 2021
Systematic review: Kinesio taping provides little or no benefit for rotator cuff disease.
16 Aug, 2021 | 00:52h | UTCKinesio taping for rotator cuff disease – Cochrane Library
Summary: Kinesio taping for rotator cuff disease – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1426468681677254658
Guideline: Acute abdomen in the immunocompromised patient.
16 Aug, 2021 | 01:00h | UTC
Guideline: Diagnosis and management of cutaneous lupus erythematosus – Classification, diagnosis, prevention, activity scores.
16 Aug, 2021 | 00:57h | UTC
German S3-Guideline on the treatment of Psoriasis vulgaris.
13 Aug, 2021 | 09:45h | UTC
Guideline: Diagnosis and management of cutaneous lupus erythematosus – Therapy, risk factors and other special topics.
12 Aug, 2021 | 08:55h | UTC
Psoriasis: a brief overview.
12 Aug, 2021 | 08:39h | UTCPsoriasis: a brief overview – Clinical Medicine Journal
M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.
8 Aug, 2021 | 23:40h | UTCRelated:
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Guideline summary: A Multidisciplinary collaborative approach to retinal toxic effects screening for patients taking antimalarials.
2 Aug, 2021 | 00:03h | UTCA Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (free for a limited period)
Original Guidance: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
Cohort study: Evidence of a potentially inappropriate and harmful prescribing cascade of gabapentinoid followed by a diuretic among older adults with lower back pain.
29 Jul, 2021 | 11:02h | UTCEvidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain – Journal of the American Geriatrics Society (link to abstract – $ for full-text)
Related:
Are you the victim of a prescribing cascade?
Prescribing Cascade in a Cardiology Practice
Review: Anabolic Therapy for Osteoporosis.
28 Jul, 2021 | 09:48h | UTCAnabolic Therapy for Osteoporosis – JAMA (free for a limited period)
Author interview: Anabolic Therapy for Osteoporosis
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.
28 Jul, 2021 | 09:44h | UTC
The use and impact of monoclonal antibody biologics during pregnancy.
28 Jul, 2021 | 09:43h | UTC
RCT: Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders.
22 Jul, 2021 | 10:42h | UTCCommentaries: Optimising treatment for patients with rotator cuff disorders – The Lancet (free registration required)
Commentary on Twitter (thread – click for more)
The much-anticipated GRASP trial for rotator cuff pain has just been published showing steroid injections have a small short-lasting benefit, and that physio led exercise was no better than patient led exercise… Here's my short Twitter review… 1/12 https://t.co/1TFYGoAi7X
— The Sp⚽️rts Physio (@AdamMeakins) July 13, 2021
Sacroiliac joint dysfunction: pathophysiology, diagnosis, and treatment.
21 Jul, 2021 | 10:26h | UTCSacroiliac joint dysfunction: pathophysiology, diagnosis, and treatment – European Spine Journal
Sarcoidosis: A clinical overview from symptoms to diagnosis.
15 Jul, 2021 | 08:58h | UTCSarcoidosis: A Clinical Overview from Symptoms to Diagnosis – Cells
2021 ACR Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
13 Jul, 2021 | 09:41h | UTC
2021 ACR Guideline for the Management of Polyarteritis Nodosa.
13 Jul, 2021 | 09:37h | UTC
2021 ACR Guideline for the Management of ANCA–Associated Vasculitis.
9 Jul, 2021 | 10:09h | UTC
M-A: Little benefit from muscle relaxants for adults with non-specific low back pain.
9 Jul, 2021 | 10:02h | UTCCommentary: New analysis finds muscle relaxant drugs to be largely ineffective for low back pain – News Medical
Related studies: M-A: Effectiveness of treatments for acute and subacute mechanical non-specific low back pain AND RCT: Little benefit from osteopathic manipulative treatment on activity limitations in patients with nonspecific subacute and chronic low back pain AND M-A: Little benefit from antidepressants for low back pain AND Meta-analysis: Little benefit from antidepressants for the treatment of back pain and osteoarthritis AND ACP/AAFP Guideline: Nonpharmacologic and pharmacologic management of acute pain from non–low back, musculoskeletal injuries in adults
Commentaries on Twitter
Muscle relaxants are largely ineffective for #lowback #pain. They might increase the risk of side effects.
Published today in @bmj_latest ⬇️
Proud to be a part of this excellent team led by @AidanCashin
Paper: https://t.co/4p7gd7PJIe pic.twitter.com/3CLvL7JUfI
— Hayley Leake (@HayleyLeake) July 8, 2021
This systematic review found very low certainty evidence that muscle relaxant drugs for the treatment of acute low back pain might provide a small and not clinically meaningful improvement in pain intensity at two weeks or less @Pain_NeuRa https://t.co/HGwN4Oekrq
— The BMJ (@bmj_latest) July 8, 2021
Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach.
9 Jul, 2021 | 09:47h | UTC
Guideline | Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring.
6 Jul, 2021 | 10:03h | UTCExecutive summary: Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring – Royal College of Ophthalmologists
M-A: The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis.
6 Jul, 2021 | 09:54h | UTC
Consensus-based recommendations for the management of juvenile systemic sclerosis
2 Jul, 2021 | 11:08h | UTCConsensus-based recommendations for the management of juvenile systemic sclerosis – Rheumatology
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
22 Jun, 2021 | 10:04h | UTC